Delivery Order SPE2DB20D2104-SPE2DB24FMABJ

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,318.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a medical product, and has an ultimate completion date of June 28, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,097.83 firm fixed-price delivery order is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S" medical products. The contract has a completion date of July 12, 2024 and was awarded on July 11, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,074.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of medical supplies, specifically "ESTROGEN-METHYLTESTOS H.S. TAB 100S", to support federal healthcare programs, including military treatment facilities and veteran's healthcare services. The contract is a delivery order with a firm fixed price, and it has a completion date of January 7,...
This federal contract award, valued at $1,195.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of "ESTROGEN-METHYLTESTOS F.S. TAB 100S", a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a Firm Fixed Price agreement. There is no set-aside designation on this award. Amerisourcebergen...
This federal contract award, valued at $1,381.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,752.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a medical product, with a completion date of November 13, 2023. The contract is a Firm Fixed Price (FFP) arrangement and was not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,017.40 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 29, 2023, with a completion date of August 30, 2023. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order valued at $3,046.82 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrogen-Methyltestos H.S. Tab 100s, a pharmaceutical product, with a completion date of July 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $1,346.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrogen-Methyltestos F.S. Tablets in quantities of 100s, with a completion date of June 22, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, with a ceiling value of $1,444.13 and an ultimate completion date of April 4, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition....
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMABJ
    Delivery Order

This federal contract award, valued at $2,246.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "ESTROGEN-METHYLTESTOS F.S. TAB 100S" and has an ultimate completion date of August 27, 2024.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 1:12 PM